Wellington Management Group’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-320,849
Closed -$9.54M 1817
2023
Q1
$9.54M Sell
320,849
-130,413
-29% -$3.79M ﹤0.01% 1114
2022
Q4
$12.2M Sell
451,262
-5,452
-1% -$133K ﹤0.01% 1037
2022
Q3
$9.95M Sell
456,714
-269,325
-37% -$7.04M ﹤0.01% 1102
2022
Q2
$19.9M Buy
726,039
+4,964
+0.7% +$143K ﹤0.01% 947
2022
Q1
$24.2M Sell
721,075
-604,599
-46% -$19.5M ﹤0.01% 972
2021
Q4
$46M Buy
1,325,674
+969,649
+272% +$31.3M 0.01% 857
2021
Q3
$11.1M Sell
356,025
-3,350,442
-90% -$114M ﹤0.01% 1247
2021
Q2
$135M Sell
3,706,467
-232,329
-6% -$9.61M 0.02% 550
2021
Q1
$172M Sell
3,938,796
-367,042
-9% -$17.2M 0.03% 461
2020
Q4
$198M Buy
4,305,838
+318,996
+8% +$13.3M 0.04% 413
2020
Q3
$132M Buy
3,986,842
+694,085
+21% +$22.2M 0.03% 464
2020
Q2
$96.8M Buy
3,292,757
+1,042,636
+46% +$30.2M 0.02% 533
2020
Q1
$60.6M Buy
2,250,121
+57,482
+3% +$1.72M 0.02% 577
2019
Q4
$73.9M Buy
2,192,639
+102,486
+5% +$3.71M 0.02% 657
2019
Q3
$78.3M Buy
2,090,153
+461,550
+28% +$17.6M 0.02% 604
2019
Q2
$71M Buy
1,628,603
+27,412
+2% +$1.17M 0.02% 656
2019
Q1
$68.3M Buy
1,601,191
+514,415
+47% +$23M 0.02% 650
2018
Q4
$48.7M Buy
1,086,776
+885,982
+441% +$46.4M 0.01% 716
2018
Q3
$13.8M Sell
200,794
-88,003
-30% -$5.66M ﹤0.01% 1193
2018
Q2
$16.5M Buy
+288,797
New +$15.3M ﹤0.01% 1138
2017
Q1
Sell
-23,871
Closed -$883K 2240
2016
Q4
$883K Sell
23,871
-15,843
-40% -$566K ﹤0.01% 1887
2016
Q3
$1.38M Buy
39,714
+26,647
+204% +$933K ﹤0.01% 1763
2016
Q2
$425K Buy
+13,067
New +$400K ﹤0.01% 1941

Other funds holding AVNS

Wellington Management Group's AVNS Position: Q2 2023 in Review

Wellington Management Group sold out of Avanos Medical (AVNS) in Q2 2023, closing a stake of 320,849 shares — an estimated $9.54M sold.

Wellington Management Group first reported a position in AVNS in Q2 2016 and held it in 23 quarters. The position peaked at $198M in Q4 2020. 274 funds tracked by Wall St. Rank hold AVNS as of Q2 2023.

  • Wellington Management Group reported no remaining Avanos Medical position as of Q2 2023 after selling out during the quarter.
  • Wellington Management Group sold 320,849 Avanos Medical shares in Q2 2023, an estimated $9.54M.
  • Wellington Management Group first reported a position in Avanos Medical in Q2 2016 and held it in 23 quarters.
  • Wellington Management Group's Avanos Medical position peaked at $198M in Q4 2020.
  • 274 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2023.

Based on Wellington Management Group's 13F filing for Q2 2023, filed 14 Aug 2023.